Panacea Biotec on Monday inked a tripartite pact with Natco Pharma and Breckenridge Pharmaceutical Inc to manufacture and supply Azacitidine injection, a chemotherapy drug, for the US market. Under its terms, Natco has provided the technology for manufacturing Azacitidine to Panacea Biotec’s Baddi facility. Panacea will manufacture and supply the product, which will be marketed and distributed by Breckenridge in the US.